Show simple item record

dc.contributor.authorMeester, R.
dc.contributor.authorDoubeni, C.
dc.contributor.authorZauber, A.
dc.contributor.authorGoede, S.
dc.contributor.authorLevin, T.
dc.contributor.authorCorley, D.
dc.contributor.authorJemal, A.
dc.contributor.authorLansdorp-Vogelaar, Iris
dc.date.accessioned2017-03-15T22:16:46Z
dc.date.available2017-03-15T22:16:46Z
dc.date.created2017-02-26T19:31:38Z
dc.date.issued2015
dc.identifier.citationMeester, R. and Doubeni, C. and Zauber, A. and Goede, S. and Levin, T. and Corley, D. and Jemal, A. et al. 2015. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 121 (13): pp. 2281-2285.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/49908
dc.identifier.doi10.1002/cncr.29336
dc.description.abstract

BACKGROUND: The National Colorectal Cancer Roundtable, a national coalition of public, private, and voluntary organizations, has recently announced an initiative to increase colorectal cancer (CRC) screening rates in the United States to 80% by 2018. The authors evaluated the potential public health benefits of achieving this goal. METHODS: The authors simulated the 1980 through 2030 United States population of individuals aged 50 to 100 years using microsimulation modeling. Test-specific historical screening rates were based on National Health Interview Survey data for 1987 through 2013. The effects of increasing screening rates from approximately 58% in 2013 to 80% in 2018 were compared to a scenario in which the screening rate remained approximately constant. The outcomes were cancer incidence and mortality rates and numbers of CRC cases and deaths during short-term follow-up (2013-2020) and extended follow-up (2013-2030). RESULTS: Increasing CRC screening rates to 80% by 2018 would reduce CRC incidence rates by 17% and mortality rates by 19% during short-term follow-up and by 22% and 33%, respectively, during extended follow-up. These reductions would amount to a total of 277,000 averted new cancers and 203,000 averted CRC deaths from 2013 through 2030. CONCLUSIONS: Achieving the goal of increasing the uptake of CRC screening in the United States to 80% by 2018 may have a considerable public health impact by averting approximately 280,000 new cancer cases and 200,000 cancer deaths within <20 years.

dc.publisherJohn Wiley & Sons, Inc.
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titlePublic health impact of achieving 80% colorectal cancer screening rates in the United States by 2018
dc.typeJournal Article
dcterms.source.issn0008-543X
dcterms.source.titleCancer
curtin.accessStatusOpen access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-nd/4.0/